Loading publications…
The last 5 uploaded publications
Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer
Andrisha–Jade Inderjeeth, Monique Topp, Elaine Sanij, Elena Castro, Shahneen Sandhu (2022). Clinical Application of Poly(ADP-ribose) Polymerase (PARP) Inhibitors in Prostate Cancer. , 14(23), DOI: https://doi.org/10.3390/cancers14235922.
Article62 days agoEnzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304)
Ciara Conduit, Andrisha–Jade Inderjeeth, R.J. Allen, Andrew Martin, Wendy R. Parulekar, Eibhlin Mulroe, Margaret McJannett, Robert Zielinski, Alastair Thomson, Thean Hsiang Tan, Shahneen Sandhu, M. Neil Reaume, David Pook, Scott North, Gavin Marx, Anthony M. Joshua, Lisa G. Horvath, Ray McDermott, Simon Chowdhury, Kim N., Alison Y. Zhang, Martin R. Stockler, Ian D. Davis, Christopher J. Sweeney (2025). Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304). , DOI: https://doi.org/10.1080/14796694.2024.2440277.
Article62 days agoNovel radionuclide therapy combinations in prostate cancer
Andrisha–Jade Inderjeeth, Amir Iravani, Shalini Subramaniam, Ciara Conduit, Shahneen Sandhu (2023). Novel radionuclide therapy combinations in prostate cancer. , 15, DOI: https://doi.org/10.1177/17588359231187202.
Article62 days agoHeterogeneity of canonical prostate cancer markers across lesions in metastatic castration-resistant prostate cancer.
Anna Trigos, Anupama Pasam, Andrisha–Jade Inderjeeth, Lachlan D. Cain, Sirui Weng, Vinita Gupta, Beate Sable, Katherine Paweletz, Julie M. Bailis, Yangyi Zhang, Yuzhou Feng, A. Antón, Ben Tran, Catherine Mitchell, Shahneen Sandhu (2023). Heterogeneity of canonical prostate cancer markers across lesions in metastatic castration-resistant prostate cancer.. , 41(6_suppl), DOI: https://doi.org/10.1200/jco.2023.41.6_suppl.219.
Article62 days agoImpact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review
Julia Lai‐Kwon, Andrisha–Jade Inderjeeth, Karolina Lisy, Shahneen Sandhu, Claudia Rutherford, Michael Jefford (2023). Impact of immune checkpoint inhibitors and targeted therapy on health-related quality of life of people with stage III and IV melanoma: a mixed-methods systematic review. , 184, DOI: https://doi.org/10.1016/j.ejca.2023.02.005.
Article62 days ago